SFS
ENZ

Sowell Financial Services’s Enzo Biochem, Inc. ENZ Stock Holding History

Sowell Financial Services’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,914
Closed -$10K – 3331
2020
Q4 		$10K Buy
+3,914
New +$8.52K ﹤0.01% 2032

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Sowell Financial Services's ENZ Position: Q1 2021 in Review

Sowell Financial Services sold out of Enzo Biochem, Inc. (ENZ) in Q1 2021, closing a stake of 3,914 shares — an estimated $10K sold.

Sowell Financial Services first reported a position in ENZ in Q4 2020 and held it in 1 quarter. The position peaked at $10K in Q4 2020. 82 funds tracked by Wall St. Rank hold ENZ as of Q1 2021.

  • Sowell Financial Services reported no remaining Enzo Biochem, Inc. position as of Q1 2021 after selling out during the quarter.
  • Sowell Financial Services sold 3,914 Enzo Biochem, Inc. shares in Q1 2021, an estimated $10K.
  • Sowell Financial Services first reported a position in Enzo Biochem, Inc. in Q4 2020 and held it in 1 quarter.
  • Sowell Financial Services's Enzo Biochem, Inc. position peaked at $10K in Q4 2020.
  • 82 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2021.

Based on Sowell Financial Services's 13F filing for Q1 2021, filed 7 May 2021.